• 1 Stempeutics Research Malaysia Sdn. Bhd, Technology Park Malaysia, 57000 Kuala Lumpur, Malaysia
J Transl Med, 2012;10:229.
PMID: 23171323 DOI: 10.1186/1479-5876-10-229


Numerous preclinical and clinical studies have investigated the regenerative potential and the trophic support of mesenchymal stem cells (MSCs) following their injection into a target organ. Clinicians favor the use of smallest bore needles possible for delivering MSCs into vascular organs like heart, liver and spleen. There has been a concern that small needle bore sizes may be detrimental to the health of these cells and reduce the survival and plasticity of MSCs.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.